Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

Keyphrases

• Cross-reactivity 100%
• Hybrid Capture 100%
• Human Papillomavirus Testing 100%
• Cobas 100%
• Aptima 100%
• Sample Splitting 100%
• Reaction Profile 100%
• Cervical Cancer Screening 30%
• Genotype 20%
• Positive Check 20%
• High-risk Human Papillomavirus (HR-HPV) 20%
• False-positive Test 20%
• Primary Screening 20%
• Cervical Lesions 20%
• High Risk 10%
• Low Risk 10%
• Histology 10%
• Screening Program 10%
• High-risk HPV 10%
• Histological Examination 10%
• Infection Risk 10%
• New Humanities 10%
• Precancerous Cervical Lesions 10%
• Normal Cytology 10%
• Repeated Testing 10%
• Human Papillomavirus Genotypes 10%
• Tender 10%
• HPV2 10%
• Abnormal Cytology 10%
• High-risk Human Papillomavirus Testing 10%

Immunology and Microbiology

• Cross-Reactivity 100%
• Wart Virus 100%
• Genotype 10%
• Screening 10%
• Cancer Screening 10%